Semaglutide, Liraglutide, Tirzepatide Linked to Diverse Cutaneous Adverse Events, Including Injection-Site Reactions and Dysesthesia
Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review.
Abstract
A systematic review characterized cutaneous adverse events for semaglutide, liraglutide, and tirzepatide, finding injection-site reactions (tirzepatide 2-7%) and dysesthesia (semaglutide up to 20%) are common.
TitrateLab articles covering Tirzepatide
Written by TitrateLab, separately from the study summarized above.
